Abstract
Objective
The objectives of this review are to compare the effectiveness and safety of radiochemotherapy (RTCT) with radiotherapy (RT) alone in locally advanced cervical cancer (LACC).
Data sources
We comprehensively searched the Cochrane library, Medline, EMBASE, Chinese biomedicine literature database, Chinese scientific full-text database and Chinese journal full-text database for relevant articles. The computer search was supplemented with a manual search of reference lists for all available review articles. Also reference lists of the included studies were reviewed.
Results
We included 18 randomized trials involving 3,517 patients. Meta-analysis results are as follows: the response rate, 3 and 5-year survival rates were significantly better in patients in the RTCT group than in RT group. As adverse effects, limited evidence suggests that there was no significant difference between the two groups with regard to rectitis, cystitis, nausea and vomiting. But RTCT group has higher incidence rates than RT group in gastrointestinal, myelosuppression and leucopenia.
Conclusion
The combination of radiotherapy and chemotherapy was more effective for LACC than radiotherapy alone. There was no significant difference between the RTCT regimen group and RT regimen group with regard to adverse effects.
Similar content being viewed by others
References
Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340(15):1144–1153
Yazigi R, Aliste G, Torres R, Ciudad AM, Cuevas M, Garrido J, Prado S, Solá A, Castillo R, Cerda B, Cumsille MA, González M, Navarro C, Reyes JM (2003) Phase III randomized pilot study comparing interferon alpha-2b in combination with radiation therapy versus radiation therapy alone in patients with stage III-B carcinoma of the cervix. Int J Gynecol Cancer 13(2):164–169
Cai HB, Chen HZ, Yin HH (2006) Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res 32(3):315–323
De Vincenzo R, Amadio G, Ricci C, Licameli A, Ferrandina G, Capelli G, Scambia G (2009) Treatment of cervical cancer in Italy: strategies and their impact on the women. Vaccine 27:A39–A45. doi:10.1016/j.vaccine.2008.11.110
Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 341(9):695–696
Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of intervention 5.0.0. The cochrane colloboration 2008. Available from http://www.cochrane-handbook.org
Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen (2008)
Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186
DeMets DL (1987) Methods for combining randomized clinical trials: strengths and limitations. Stat Med 6(3):341–350
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188. doi:10.1016/0197-2456(86)90046-2
Ma AP, Li XF, Li F (2009) Clinical analysis of concurrent chemotherapy and radiotherapy for advanced cervical Cancer. J Hainan Med Coll 15(2):138–141
Herod J, Burton A, Buxton J, Tobias J, Luesley D, Jordan S, Dunn J, Poole CJ (2000) A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. Ann Oncol 11(9):1175–1181
Fu HX (2007) Clinical analysis of BP chemotherapy plus radiotherapy for middle and advanced cervical cancer. Med Inform 20(9):1680–1681
Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340(15):1154–1161
Monk BJ, Wang J, Im S, Stock RJ, Peters WA 3rd, Liu PY, Barrett RJ 2nd, Berek JS, Souhami L, Grigsby PW, Gordon W Jr, Alberts DS (2005) Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 96(3):721–728
Nagy V, Coza O, Ordeanu C, Trăilă A, Rancea A, Todor N, Ghilezan N (2009) Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 185(3):177–183. doi:10.1007/s00066-009-1893-z
Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D (2002) Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol Feb 20(4):966–972. 0732-183X/02/2004-966
Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18(8):1606–1613. 0732-183X/00/1808-1606
Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D (2007) Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 197(5):503.e1–503.e6
Yang SL (2003) The analysis of radiotherapy alone with radiotherapy and chemotherapy in patients with advanced cervical cancer. Henan J Oncol 116(12):135–136
Fu WH, Chen LP, Huang SS, Lin L (2008) Synchronous radiotherapy and chemotherapy for advanced cervical cancers. Int Med Health Guid News 14(6):23–25
Wang X, Zhang L, Du XP, Zhang LQ, Zhang LZ (2007) Clinical study on concurrent chemoradiotherapy for locally advanced cervical cancer. Acta Acad Med Xuzhou 27(6):387–388
Chen YJ, Zhang Y, Zhou W (2008) Clinical Analysis of concurrent chemoradiation in middle and advanced cervical cancer. J Yangtze Univ 5(1):6–9
Chen YJ, Xu YH (2008) Clinical Analysis of chemoradiation in advanced cervical cancer. Shandong Med J 48(42):113
Gao Y, Liu Z, Chen HW (2009) The study of concurrent chemoradiotherapy in medium-term and advanced cervical carcinoma the uterine cervix. Chin J Pract Gynecol Obstet 5(1):46–48
Lu YF, Cheng HJ, Dan J, Wang W, Yao ZW, Xie CF (2004) Concurrent chemotherapy plus radiotherapy for stage II–III cervical cancer. Chin J Clin Oncol Rehabil 11(5):438–439
Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17(5):1339–1348. 0732-183X/99/1705-1339
Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, Williams C, Collingwood M (2005) Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev Jul 20(3):CD002225
Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358(9284):781–786
Acknowledgments
We thank the following individuals for helpful comments at various stages of the review process: Lei jiang, Wen-Zhen Yuan, Peng Zhao, Xiao-Wei Wang, Yong-Xun Zhao.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, N., Guan, QL., Wang, K. et al. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet 283, 103–108 (2011). https://doi.org/10.1007/s00404-010-1385-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1385-5